Jianpi Huayu Decoction enhances the effect of sorafenib and alleviates adverse events in hepatocellular carcinoma by remodeling the gut microbiota
Background: There is an urgent need for effective treatment for advanced hepatocellular carcinoma (HCC). Sorafenib, a multi-kinase inhibitor, is the first-line treatment for advanced HCC, which has a modest efficacy due to severe adverse effects (AEs), acquired resistance, and others. Jianpi Huayu D...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2022-03-01
|
| シリーズ: | Pharmacological Research - Modern Chinese Medicine |
| 主題: | |
| オンライン･アクセス: | http://www.sciencedirect.com/science/article/pii/S2667142522000185 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|